PMID

Data

Article Title

Organization

Carbamoylphosphonates control tumor cell proliferation and dissemination by simultaneously inhibiting carbonic anhydrase IX and matrix metalloproteinase-2. Toward nontoxic chemotherapy targeting tumor microenvironment.

The Hebrew University of Jerusalem

Backbone cyclic peptidomimetic melanocortin-4 receptor agonist as a novel orally administrated drug lead for treating obesity.

The Hebrew University of Jerusalem

Carbamoylphosphonate matrix metalloproteinase inhibitors 6: cis-2-aminocyclohexylcarbamoylphosphonic acid, a novel orally active antimetastatic matrix metalloproteinase-2 selective inhibitor--synthesis and pharmacodynamic and pharmacokinetic analysis.

The Hebrew University of Jerusalem

Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.

The Hebrew University of Jerusalem

Backbone cyclic peptide inhibitors of protein kinase B (PKB/Akt).

The Hebrew University of Jerusalem

Anticonvulsant 4-aminobenzenesulfonamide derivatives with branched-alkylamide moieties: X-ray crystallography and inhibition studies of human carbonic anhydrase isoforms I, II, VII, and XIV.

The Hebrew University of Jerusalem

ATP non-competitive IGF-1 receptor kinase inhibitors as lead anti-neoplastic and anti-papilloma agents.

The Hebrew University of Jerusalem

Synthesis and structure-activity relationship studies of peptidomimetic PKB/Akt inhibitors: the significance of backbone interactions.

The Hebrew University of Jerusalem

The effect of backbone cyclization on PK/PD properties of bioactive peptide-peptoid hybrids: the melanocortin agonist paradigm.

The Hebrew University of Jerusalem

Peptide inhibitors of HIV-1 integrase: from mechanistic studies to improved lead compounds.

The Hebrew University of Jerusalem

Interaction between HIV-1 Rev and integrase proteins: a basis for the development of anti-HIV peptides.

The Hebrew University of Jerusalem

Bioactive peroxides as potential therapeutic agents.

The Hebrew University of Jerusalem